Conformational Stability of the N-Terminal Region of MDM2

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 Nov 25

PMID 38005300

Authors

Bruno Rizzuti

Olga Abian

Adrian Velazquez-Campoy

Jose L Neira

Affiliations

Soon will be listed here.

Abstract

MDM2 is an E3 ubiquitin ligase which is crucial for the degradation and inhibition of the key tumor-suppressor protein p53. In this work, we explored the stability and the conformational features of the N-terminal region of MDM2 (N-MDM2), through which it binds to the p53 protein as well as other protein partners. The isolated domain possessed a native-like conformational stability in a narrow pH range (7.0 to 10.0), as shown by intrinsic and 8-anilinonapthalene-1-sulfonic acid (ANS) fluorescence, far-UV circular dichroism (CD), and size exclusion chromatography (SEC). Guanidinium chloride (GdmCl) denaturation followed by intrinsic and ANS fluorescence, far-UV CD and SEC at physiological pH, and differential scanning calorimetry (DSC) and thermo-fluorescence experiments showed that (i) the conformational stability of isolated N-MDM2 was very low; and (ii) unfolding occurred through the presence of several intermediates. The presence of a hierarchy in the unfolding intermediates was also evidenced through DSC and by simulating the unfolding process with the help of computational techniques based on constraint network analysis (CNA). We propose that the low stability of this protein is related to its inherent flexibility and its ability to interact with several molecular partners through different routes.

References

van Dieck J, Lum J, Teufel D, Fersht A . S100 proteins interact with the N-terminal domain of MDM2. FEBS Lett. 2010; 584(15):3269-74. DOI: 10.1016/j.febslet.2010.06.024. View

Neira J, Diaz-Garcia C, Prieto M, Coutinho A . The C-terminal SAM domain of p73 binds to the N terminus of MDM2. Biochim Biophys Acta Gen Subj. 2019; 1863(4):760-770. DOI: 10.1016/j.bbagen.2019.01.019. View

Kussie P, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine A . Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996; 274(5289):948-53. DOI: 10.1126/science.274.5289.948. View

Muro-Pastor M, Barrera F, Reyes J, Florencio F, Neira J . The inactivating factor of glutamine synthetase, IF7, is a "natively unfolded" protein. Protein Sci. 2003; 12(7):1443-54. PMC: 2323932. DOI: 10.1110/ps.0303203. View

Thurlkill R, Grimsley G, Scholtz J, Pace C . pK values of the ionizable groups of proteins. Protein Sci. 2006; 15(5):1214-8. PMC: 2242523. DOI: 10.1110/ps.051840806. View

Bedouelle H . Principles and equations for measuring and interpreting protein stability: From monomer to tetramer. Biochimie. 2015; 121:29-37. DOI: 10.1016/j.biochi.2015.11.013. View

McCoy M, Gesell J, Senior M, Wyss D . Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation. Proc Natl Acad Sci U S A. 2003; 100(4):1645-8. PMC: 149886. DOI: 10.1073/pnas.0334477100. View

PTITSYN O . Molten globule and protein folding. Adv Protein Chem. 1995; 47:83-229. DOI: 10.1016/s0065-3233(08)60546-x. View

Pace C, Grimsley G, Scholtz J . Protein ionizable groups: pK values and their contribution to protein stability and solubility. J Biol Chem. 2009; 284(20):13285-9. PMC: 2679426. DOI: 10.1074/jbc.R800080200. View

10.

. Protein Data Bank: the single global archive for 3D macromolecular structure data. Nucleic Acids Res. 2018; 47(D1):D520-D528. PMC: 6324056. DOI: 10.1093/nar/gky949. View

11.

Thurlkill R, Grimsley G, Scholtz J, Pace C . Hydrogen bonding markedly reduces the pK of buried carboxyl groups in proteins. J Mol Biol. 2006; 362(3):594-604. DOI: 10.1016/j.jmb.2006.07.056. View

12.

Kruger D, Rathi P, Pfleger C, Gohlke H . CNA web server: rigidity theory-based thermal unfolding simulations of proteins for linking structure, (thermo-)stability, and function. Nucleic Acids Res. 2013; 41(Web Server issue):W340-8. PMC: 3692064. DOI: 10.1093/nar/gkt292. View

13.

Momand J, Zambetti G, Olson D, George D, Levine A . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992; 69(7):1237-45. DOI: 10.1016/0092-8674(92)90644-r. View

14.

Lane D, Hall P . MDM2--arbiter of p53's destruction. Trends Biochem Sci. 1997; 22(10):372-4. DOI: 10.1016/s0968-0004(97)01119-5. View

15.

Jackson S . How do small single-domain proteins fold?. Fold Des. 1998; 3(4):R81-91. DOI: 10.1016/S1359-0278(98)00033-9. View

16.

Yadahalli S, Neira J, Johnson C, Sing Tan Y, Rowling P, Chattopadhyay A . Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2. Sci Rep. 2019; 9(1):693. PMC: 6345774. DOI: 10.1038/s41598-018-36589-5. View

17.

Saadatzadeh M, Elmi A, Pandya P, Bijangi-Vishehsaraei K, Ding J, Stamatkin C . The Role of MDM2 in Promoting Genome Stability versus Instability. Int J Mol Sci. 2017; 18(10). PMC: 5666895. DOI: 10.3390/ijms18102216. View

18.

Darling P, Holt J, Ackers G . Coupled energetics of lambda cro repressor self-assembly and site-specific DNA operator binding I: analysis of cro dimerization from nanomolar to micromolar concentrations. Biochemistry. 2000; 39(37):11500-7. DOI: 10.1021/bi000935s. View

19.

Kamijo T, Weber J, Zambetti G, Zindy F, Roussel M, Sherr C . Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A. 1998; 95(14):8292-7. PMC: 20969. DOI: 10.1073/pnas.95.14.8292. View

20.

Pfleger C, Rathi P, Klein D, Radestock S, Gohlke H . Constraint Network Analysis (CNA): a Python software package for efficiently linking biomacromolecular structure, flexibility, (thermo-)stability, and function. J Chem Inf Model. 2013; 53(4):1007-15. DOI: 10.1021/ci400044m. View